30 results
424B3
PROK
ProKidney Corp - Ordinary Shares
11 Aug 23
Prospectus supplement
9:09am
-based compensation costs of approximately $2.6 million due to the hiring of additional personnel particularly in the areas of clinical development … million was primarily driven by the following:
increases in cash-based compensation costs of approximately $5.5 million due to the hiring
424B3
h8wlnwxuv8rn16usti
26 May 23
Prospectus supplement
7:32am
424B3
2ltbmq6de 6grflmb
21 Apr 23
Prospectus supplement
4:18pm
POS AM
szd dm8a50ytnseav
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
romx jaf9h0p7
29 Nov 22
Prospectus supplement
4:18pm
8-K
EX-99.1
ymwp20pvaex9h
14 Nov 22
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10:34am
424B3
gtpsn
9 Sep 22
Prospectus supplement
5:05pm
8-K/A
EX-99.1
1i69vvvu0u5
12 Aug 22
Prokidney’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
7:16am
8-K
EX-99.1
93jtz72do9hee2xp8jl6
11 Aug 22
ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update
5:41pm
DEFM14A
l2knsc 8a
10 Jun 22
Proxy related to merger
4:54pm